A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells

Journal of Drug Targeting

Volumn 15, Issue 6, 2007, Pages 428-436

  Gao, Feng ^a,b   Kodama, Toshio ^b   Chen, Xiuhao ^b   Okada, Keisaku ^b   Honda, Takeshi ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Drug delivery; Monoclonal antibody; Polyclonal antibody; Thermostable direct hemolysin; Vibrio parahaemolyticus

Indexed keywords

ANTIBODY CONJUGATE; CYANAMIDE; HEMOLYSIN; LATEX; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; POLYMER;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; CELL STRAIN CACO 2; CHEMICAL BINDING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; VIBRIO PARAHAEMOLYTICUS;

ANTIBODIES; ANTIBODIES, MONOCLONAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; CACO-2 CELLS; DRUG CARRIERS; HEMOLYSIN PROTEINS; HUMANS; MICROSPHERES; PARTICLE SIZE; POLYMERS; VIBRIO PARAHAEMOLYTICUS; VIRULENCE FACTORS;

EID: 34447550106     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701453745     Document Type: Article

References (30)

1. Alam, MJ, Miyoshi, S. and Shinoda, S. (2003) Studies on pathogenic Vibrio parahaemolyticus during a warm weather season in the Seto inland sea, Japan. Environ Microbiol, 5, pp. 706-710.
2. Aybay, C. and Imir, T. (2000) Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells. J Immunol Methods, 233, pp. 77-81.
3. Hara-Kudo, Y., Sugiyama, K. and Nishibuchi, M. (2003) Prevalence of pandemic thermostable direct hemolysin-producing Vibrio parahaemolyticus O3:K6 in seafood and the coastal environment in Japan. Appl Environ Microbiol, 69, pp. 3883-3891.
4. Hilgers, AR, Conradi, RA and Burton, PS (1990) Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res, 7, pp. 902-910.
5. Honda, T. and Miwatani, T. (1988) Purification and characterization of a hemolysin produced by a clinical isolate of Kanagawa phenomenon-negative Vibrio parahaemolyticus and related to the thermostable direct hemolysin. Infect Immun, 56, pp. 961-965.
6. Honda, T. and Miwatani, T. (1989) Purification of a TDH-related hemolysin produced by a Kanagawa phenomenon-negative clinical isolate of Vibrio parahaemolyticus 06:K46. FEMS Microbiol Lett, 48, pp. 241-245.
7. Honda, T., Yoh, M. and Miwatani, T. (1989) Production of monoclonal antibodies against thermostable direct hemolysin of Vibrio parahaemolyticus and application of the antibodies for enzyme-linked immunosorbent assay. Med Microbiol Immunol, 178, pp. 245-253.
8. Honda, T., Honda, S., Ni, YX and Miwatani, T. (1990) Development and application of enzyme-linked immunosorbent assay using monoclonal antibody against a hemolysin (Vp-TRH) of Vibrio paraheamolyticus-evidence that Vp-TRH producing-Kanagawa phenomenon-negative V. parahaemolyticus is a human pathogen. Kansenshogaku Zasshi, 64, pp. 767-773.
9. Iida, T., Suthienkul, O. and Park, KS (1997) Evidence for genetic linkage between the ure and trh genes in Vibrio parahaemolyticus. J Med Microbiol, 46, pp. 639-645.
10. Iida, T., Park, KS and Suthienkul, O. (1998) Close proximity of the tdh, trh and ure genes on the chromosome of Vibrio parahaemolyticus. Microbiology, 144, pp. 2517-2523.
11. Kawamura, N., Yamazaki, T. and Tamai, H. (1999) Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr Int, 41, pp. 218-222.
12. Lowry, OH, Rosebrough, N., Farr, AL and Randall, RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem, 193, pp. 257-265.
13. Nagayama, K., Oguchi, T., Arita, M. and Honda, T. (1994) Correlation between cell-associated mannose-sensitive hemagglutination by Vibrio parahaemolyticus and adherence to a human colonic cell line Caco-2. FEMS Microbiol Lett, 120, pp. 207-210.
14. Nagayama, K., Yamamoto, K., Mitawani, T. and Honda, T. (1995) Characterisation of a haemolysin related to Vp-TDH produced by a Kanagawa phenomenon-negative clinical isolate of Vibrio parahaemolyticus. J Med Microbiol, 42, pp. 83-90.
15. Nakao, H., Kiyokawa, N., Fujimoto, J., Yamasaki, S. and Takeda, T. (1999) Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity. Infect Immun, 67, pp. 5717-5722.
16. Nasu, H., Iida, T. and Sugahara, T. (2000) A filamentous phage associated with recent pandemic Vibrio parahaemolyticus O3:K6 strains. J Clin Microbiol, 38, pp. 2156-2161.
17. Nishibuchi, M., Fasano, A., Russell, RG and Kaper, JB (1992) Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun, 60, pp. 3539-3545.
18. Ohta, K., Kudoh, Y. and Tsuno, M. (1979) Development of a sensitive serological assay based on reversed passive hemagglutination for detection of enteropathogenic toxin (kanagawa hemolysin) of Vibrio parahaemolyticus, and re-evaluation of the toxin producibility of isolates from various sources. Nippon Saikingaku Zasshi, 34, pp. 837-846.
19. Osawa, R., Arakawa, E., Okitsu, T., Yamai, S. and Watanabe, H. (2002) Levels of thermostable direct hemolysin produced by Vibrio parahaemolyticus O3:K6 and other serovars grown anaerobically with the presence of a bile acid. Curr Microbiol, 44, pp. 302-305.
20. Pallasch, TJ (2003) Antibiotic resistance. Dent Clin North Am, 47, pp. 623-639.
21. Rakita, RM, Quan, VC and Jacques-Palaz, K. (2000) Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium. FEMS Immunol Med Microbiol, 28, pp. 291-299.
22. Rivier, D. and Sobotka, J. (1978) Protective effect of rabbit immune serum administered orally to rats infected by a human pathogenic strain of E. coli. Exp Cell Biol, 46, pp. 277-288.
23. Safdar, N., Said, A., Gangnon, RE and Maki, DG (2002) Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: A meta-analysis. JAMA, 288, pp. 996-1001.
24. Siiman, O., Burshteyn, A. and Insausti, ME (2001) Covalently bound antibody on polystyrene latex beads: Formation, stability, and use in analyses of white blood cell populations. J Colloid Interface Sci, 234, pp. 44-58.
25. Suthienkul, O., Iida, T. and Park, KS (1996) Restriction fragment length polymorphism of the tdh and trh genes in clinical Vibrio parahaemolyticus strains. J Clin Microbiol, 34, pp. 1293-1295.
26. Widders, PR, Thomas, LM, Long, KA, Tokhi, MA, Panaccio, M. and Apos, E. (1998) The specificity of antibody in chickens immunised to reduce intestinal colonisation with Campylobacter jejuni. Vet Microbiol, 64, pp. 39-50.
27. Wong, CS, Jelacic, S., Habeeb, RL, Watkins, SL and Tarr, PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med, 342, pp. 1930-1936.
28. Iida, T., Yamamoto, K., Takarada, Y., Miwatani, T. and Honda, T. (1994) Demonstration and characterization of simultaneous production of a thermostable direct hemolysin (TDH/I) and a TDH-related hemolysin (TRHx) by a clinically isolated Vibrio parahaemolyticus strain, TH3766. Infect Immun, 62, pp. 166-171.
29. Yeung, PS, Hayes, MC, DePaola, A., Kaysner, CA, Kornstein, L. and Boor, KJ (2002) Comparative phenotypic, molecular, and virulence characterization of Vibrio parahaemolyticus O3:K6 isolates. Appl Environ Microbiol, 68, pp. 2901-2909.
30. Yoh, M. and Honda, T. (1997) The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Epidemiol Infect, 119, pp. 101-103.